Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial

NCT03738956 is registered in ClinicalTrials.gov with Globe Pharmaceuticals Limited as lead sponsor.

NCT NCT03738956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03738956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial
Lead sponsor
Globe Pharmaceuticals Limited
Phase
Phase 2/3
Overall status
Unknown status
Start date
September 1, 2017
Completion date
December 31, 2018
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

axial spondyloarthritis